Sort
51,570 grants matching “autoimmune disease”
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
$732,134Wei-Jun Qian · Battelle Pacific Northwest Laboratories · R01 · FY2022 · DK
Non-linear transduction of TCR signals leading to Ras activation
$732,129Jeroen Roose · University Of California, San Francisco · P01 · FY2015 · AI
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
$732,031Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AR
Regulation of human dendritic cell activation
$731,778Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Balanced signaling cues to guide cell transitions in the blood lineage continuum
$731,747Jeroen Roose · University Of California, San Francisco · R01 · FY2018 · HL
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
$731,706Stefanie Sarantopoulos · Duke University · R01 · FY2022 · HL
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
$731,706Stefanie Sarantopoulos · Duke University · R01 · FY2023 · HL
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
$731,706Stefanie Sarantopoulos · Duke University · R01 · FY2025 · HL
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance
$731,602Andrew D Wells · Children'S Hosp Of Philadelphia · R01 · FY2025 · AI
Linking antibody sequences to function at the single-cell level using nanovial technology
$731,568Joseph De Rutte · Partillion Bioscience Corporation · R44 · FY2024 · GM
Leveraging early-life microbes to prevent type 1 diabetes
$731,556Michael A Silverman · Children'S Hosp Of Philadelphia · R01 · FY2025 · DK
Mechanisms for regulation of a novel class of anti-diabetic lipids
$731,406Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2024 · DK
Inflammation, Macrophage Differentiation, and Cancer
$731,310Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Rheumatic and Autoimmune Diseases in Minority Communities
$731,274Michael Ward · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR
Immune Dysregulation During Multiple Sclerosis Relapse
$731,251Nitin J Karandikar · University Of Iowa · R01 · FY2016 · AI
Antibody-based therapeutic strategy for New World mammarenavirus hemorrhagic fever
$731,002Manuel L Penichet · University Of California Los Angeles · R01 · FY2025 · AI
Inborn errors of immunity in patients with life-threatening COVID-19
$730,959Jean-Laurent Casanova · Rockefeller University · R01 · FY2024 · AI
Building the foundations of commensal vaccines
$730,870Michael Andrew Fischbach · Stanford University · R01 · FY2025 · AI
Posttranslational Neoantigens in Autoimmunity and Metabolism in T1D
$730,784Mark J. Mamula · Yale University · R01 · FY2025 · DK
Posttranslational Neoantigens in Autoimmunity and Metabolism in T1D
$730,784Mark J. Mamula · Yale University · R01 · FY2024 · DK
Cellular Immunotherapy for Systemic Sclerosis
$730,718Joana M Murad · Celdara Medical, Llc · R44 · FY2020 · AR
Comprehensive Candidate Pathway Analysis in SLE
$730,678Patrick M Gaffney · Oklahoma Medical Research Foundation · R01 · FY2009 · AI
Systematic validation of biomarkers predictive of IA and T1D and their relationship with disease development
$730,660Ernesto Satoshi Nakayasu · Battelle Pacific Northwest Laboratories · R01 · FY2024 · DK
In Vivo Gene Editing of B cells with NICE-AAV Vectors
$730,441Christopher W Peterson · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Programming dendritic cells in concert with morphagen delivery for periodontal re
$730,323David J Mooney · Harvard University · R01 · FY2009 · DE